Preview: Professional Holding’s Earnings

Professional Holding (NASDAQ:PFHD) is set to give its latest quarterly earnings report on Thursday, 2022-07-28. Here's what investors need to know before the announcement. Analysts estimate that Professional Holding will report an earnings per share (EPS) of $0.38.

Professional Holding (NASDAQ:PFHD) is set to give its latest quarterly earnings report on Thursday, 2022-07-28. Here’s what investors need to know before the announcement.

Analysts estimate that Professional Holding will report an earnings per share (EPS) of $0.38.

Professional Holding bulls will hope to hear the company to announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed EPS by $0.17, which was followed by a 0.0% drop in the share price the next day.

Here’s a look at Professional Holding’s past performance and the resulting price change:

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.34 0.38 0.42 0.40
EPS Actual 0.17 0.29 0.45 0.45
Price Change % -2.65% -1.83% 0.27% 0.34%

eps graph

Stock Performance

Shares of Professional Holding were trading at $21.89 as of July 26. Over the last 52-week period, shares are up 7.26%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Professional Holding visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Recap: Immunome Q2 Earnings

Immunome (NASDAQ:IMNM) reported its Q2 earnings results on Friday, August 5, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings Immunome beat estimated earnings by 1.33%, reporting an EPS of $-0.74 versus an estimate of $-0.75.

IMNM

Read More

UnitedHealth’s Q1 Medical Cost Update, Prudent Outlook Eases Investor Concerns: Goldman Sachs

UnitedHealth impresses with Q1 results amid the aftermath of the Change Healthcare cyberattack and maintains strong guidance amidst business disruption costs. Goldman Sachs reaffirms Buy rating, citing favorable medical cost updates and prudent outlook, despite cyberattack-related challenges.

UNH